How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
Abstract Background The aims of this research were to provide a better understanding of the specific evidence needs for assessment of clinical and cost-effectiveness of cell and gene therapies, and to explore the extent that the relevant categories of evidence are considered in health technology ass...
Bewaard in:
Hoofdauteurs: | , , , , , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
BMC,
2023-05-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |